Liver cyst
|
0.010 |
Biomarker
|
disease |
BEFREE |
Within 8 min of the intravenous administration of secretin, secretion of fluid increased in two of three hepatic cysts and in the renal cyst.
|
1970324 |
1990 |
Simple renal cyst
|
0.010 |
Biomarker
|
disease |
BEFREE |
Within 8 min of the intravenous administration of secretin, secretion of fluid increased in two of three hepatic cysts and in the renal cyst.
|
1970324 |
1990 |
Renal cyst
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Within 8 min of the intravenous administration of secretin, secretion of fluid increased in two of three hepatic cysts and in the renal cyst.
|
1970324 |
1990 |
Tachycardia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Secretin increased heart rate by 14 beats/min (20% above base-line) and this also was not altered by propranolol pretreatment.
|
2103752 |
1990 |
Tachyarrhythmia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effect of propranolol on secretin-induced gastrin release and secretin-induced tachycardia in patients with the Zollinger-Ellison syndrome.
|
2103752 |
1990 |
Zollinger-Ellison syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
We present the history of a 48-year-old man with primary hyperparathyroidism and Zollinger-Ellison syndrome who underwent acid secretory studies and secretin stimulation tests before and after parathyroidectomy.
|
3798319 |
1987 |
Neurilemmoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the current study, SCT-1 cells, a Schwannoma cell line derived from a transgenic mouse, were transfected with a human NGF (hNGF) cDNA.
|
7728338 |
1995 |
Cystic Fibrosis
|
0.040 |
Biomarker
|
disease |
BEFREE |
Renal function and renotropic effects of secretin in cystic fibrosis.
|
9348270 |
1997 |
Autistic Disorder
|
0.330 |
Biomarker
|
disease |
BEFREE |
The study of the transcriptional control of human secretin and its receptor should shed light on the pathological developments of pancreatic cancer and autism in the future.
|
10437774 |
1999 |
Pancreatic carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The study of the transcriptional control of human secretin and its receptor should shed light on the pathological developments of pancreatic cancer and autism in the future.
|
10437774 |
1999 |
Malignant neoplasm of pancreas
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
The study of the transcriptional control of human secretin and its receptor should shed light on the pathological developments of pancreatic cancer and autism in the future.
|
10437774 |
1999 |
Pancreatic carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The KRM incidence was found to be relatively high for the patients with PCa and BTCa by MASA, which is a highly sensitive method, although the incidence of KRM in DA from the patients with PCa was not as high as the incidence in their PPJ with secretin stimulation.
|
10526271 |
1999 |
Cholecystolithiasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
DA was collected endoscopically without secretin stimulation immediately after the ERCP procedure from 160 patients: 38 patients with PCa, 38 with chronic pancreatitis (CP), 22 with BTCa, 20 with adenomyomatosis of the gallbladder (AGB), 22 with cholecystolithiasis (CCL), and 20 control subjects.
|
10526271 |
1999 |
CATARACT, COPPOCK-LIKE
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
DA was collected endoscopically without secretin stimulation immediately after the ERCP procedure from 160 patients: 38 patients with PCa, 38 with chronic pancreatitis (CP), 22 with BTCa, 20 with adenomyomatosis of the gallbladder (AGB), 22 with cholecystolithiasis (CCL), and 20 control subjects.
|
10526271 |
1999 |
Biliary Tract Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The KRM incidence was found to be relatively high for the patients with PCa and BTCa by MASA, which is a highly sensitive method, although the incidence of KRM in DA from the patients with PCa was not as high as the incidence in their PPJ with secretin stimulation.
|
10526271 |
1999 |
Acute GVH disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Four patients died after allo-SCT during the study period from either acute GVHD (grade IV), pneumonitis, gastrointestinal bleeding or renal insufficiency.
|
11244433 |
2001 |
Adult T-Cell Lymphoma/Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results strongly suggest that allo-SCT may improve the survival in ATL if a controlled degree of GVHD develops.
|
11244433 |
2001 |
Kidney Failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
Four patients died after allo-SCT during the study period from either acute GVHD (grade IV), pneumonitis, gastrointestinal bleeding or renal insufficiency.
|
11244433 |
2001 |
Renal Insufficiency
|
0.010 |
Biomarker
|
disease |
BEFREE |
Four patients died after allo-SCT during the study period from either acute GVHD (grade IV), pneumonitis, gastrointestinal bleeding or renal insufficiency.
|
11244433 |
2001 |
Leukemia, Myelocytic, Acute
|
0.100 |
Biomarker
|
disease |
BEFREE |
In conclusion our study could provide some guidelines for AML therapy: (1) patients in the 'favorable' karyotype group seem to have a longer DFS when treated with an intensive induction/consolidation regimen, adopted before auto-SCT instead of standard induction; this underlines the importance of reinforcement of chemotherapy, not necessarily based on repeated high-dose AraC cycles.
|
11417475 |
2001 |
Acute monocytic leukemia
|
0.090 |
Biomarker
|
disease |
BEFREE |
In conclusion our study could provide some guidelines for AML therapy: (1) patients in the 'favorable' karyotype group seem to have a longer DFS when treated with an intensive induction/consolidation regimen, adopted before auto-SCT instead of standard induction; this underlines the importance of reinforcement of chemotherapy, not necessarily based on repeated high-dose AraC cycles.
|
11417475 |
2001 |
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME
|
0.030 |
Biomarker
|
disease |
BEFREE |
Patients receiving allo-SCT had significantly longer DFS (P = 0.005); in particular, allo-SCT significantly improved DFS in the 'favorable' and 'intermediate' groups (P = 0.04 and P = 0.048, respectively).
|
11417475 |
2001 |
Anemia, Sickle Cell
|
0.040 |
Biomarker
|
disease |
BEFREE |
The situation with SCT is different; there will continue to be the identification of parents who have the potential for having a child with a sickle cell disease but because they will not be tested or counseled, there will continue to be a population of children with a sickle cell disease whose parents have not been enabled to make informed decisions that they believe are in their best interest relative to family planning.
|
11499064 |
2001 |
Lymphoma
|
0.010 |
Biomarker
|
group |
BEFREE |
All lymphomas occurred in the setting of allo-SCT and had a rapid clinical course.
|
11502981 |
2001 |
Cystic Fibrosis
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
There were significant increases in CF intestinal mRNA levels for secretin (310% of normal, P < 0.001) and vasoactive intestinal peptide (148% of normal, P < 0.05).
|
11557509 |
2001 |